Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Cancers|March 10, 2022
Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast CancerNour Abuhadra, Ryan Sun, Jennifer K Litton, et al.
Pediatrics|June 2, 2022
Maternal High-Dose DHA Supplementation and Neurodevelopment at 18-22 Months of Preterm ChildrenMireille Guillot, Anne Synnes, Etienne Pronovost, et al.
Cancers|July 14, 2023
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective TrialNour Abuhadra, Ryan Sun, Clinton Yam, et al.
European Journal of Endocrinology|July 25, 2025
rhPTH(1-84) for hypoparathyroidism: a randomized study of patient-reported outcomesMaria Luisa Brandi, Tamara Vokes, Natasha M Appelman-Dijkstra, et al.
Annals of Surgery|June 16, 2023
Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 TrialRita A Mukhtar, Harrison Chau, Hannah Woriax, et al.
Therapeutic Advances in Medical Oncology|August 7, 2023
PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimensHui Chen, Qingqing Ding, Laila Khazai, et al.
NPJ Breast Cancer|May 22, 2020
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trialsJan Hudeček, Leonie Voorwerk, Maartje van Seijen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast CancerClinton Yam, Er-Yen Yen, Jeffrey T Chang, et al.
JAMA Network Open|December 28, 2023
Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast CancerBeverly Kyalwazi, Christina Yau, Michael J Campbell, et al.
Breast Cancer Research and Treatment|March 27, 2025
Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancerEileen Shinn, David Zahrieh, Angela DeMichele, et al.
Pageof 14